![Actinomycosis mimicking malignancy](https://sbmt.org.br/wp-content/uploads/2024/07/img-05.jpg)
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
14/10/2020
**Esta reportagem reflete exclusivamente a opinião do entrevistado.**